SCHEMBL28906226

SCHEMBL28906226

CN1CCN(c2ccc(-c3cnc4[nH]cc(I)c4n3)cc2C#N)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 3/20 0.47
ROCK1 Q13464 3/20 0.47
CDC42BPB Q9Y5S2 3/20 0.47
MAP4K1 Q92918 3/20 0.47
CDC42BPA Q5VT25 1/20 0.44
XDH P47989 1/20 0.43
TNIK Q9UKE5 3/20 0.42
CHEK1 O14757 3/20 0.39
TBK1 Q9UHD2 2/20 0.39
PAK1 Q13153 1/20 0.38
DYRK1A Q13627 1/20 0.37
DYRK1B Q9Y463 1/20 0.37
LRRK2 Q5S007 1/20 0.37
ACHE P22303 1/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
PTBP1 P26599 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CCNA1 P78396 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28507472 0.86 MAP4K1 (0.49) ROCK2ROCK1CDC42BPBMAP4K1
SCHEMBL28508735 0.84 MAP4K1 (0.61) MAP4K1TNIKPAK1
SCHEMBL28507178 0.82 TNIK (0.50) ROCK2ROCK1CDC42BPBMAP4K1CDC42BPA
SCHEMBL28906256 0.82 MAP4K1 (0.63) MAP4K1CHEK1DYRK1AKDM4E
SCHEMBL28514903 0.80 MAPK1 (0.51) ROCK2ROCK1CDC42BPBCDC42BPAXDH
SCHEMBL21590294 0.79 ROCK2 (0.52) ROCK2ROCK1CDC42BPBMAP4K1CDC42BPA
SCHEMBL28504524 0.78 MAP4K1 (0.46) ROCK2ROCK1CDC42BPBMAP4K1CDC42BPA
SCHEMBL28769137 0.78 MAP4K1 (0.49) ROCK2ROCK1MAP4K1TNIKPAK1
SCHEMBL29888838 0.78 MAP4K1 (0.49) ROCK2ROCK1MAP4K1TNIKPAK1
SCHEMBL21592703 0.77 MAP4K1 (0.50) MAP4K1XDHTNIKTBK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed